Rallybio (RLYB) Non Operating Income (2020 - 2026)
Rallybio's Non Operating Income came in at $778,000 for Q3 2026, down 96.6% from $22.94 million a year earlier and down 98.5% from the prior quarter.
Powered by 
Analysis
Rallybio (RLYB) Non Operating Income (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Rallybio reported Non Operating Income of $52.44 million, up 106.5% year-over-year; for FY2025, it came in at $24.96 million, up 403.2% from FY2024.
- Non Operating Income carries a five-year compound annual growth rate of 133.1% (FY2020 to FY2025).
- Going back by year, Non Operating Income was $4.96 million in FY2024 (-22.6%), $6.41 million in FY2023 (+178.0%), $2.31 million in FY2022 and $140,000 in FY2021 (-61.4%).
- The five-year range for quarterly Non Operating Income is $121,000 (Q4 2021) to $50.64 million (Q2 2026).
- The fastest year-over-year change in Non Operating Income over five years came in Q4 2022 (growth of 810.7%), and the weakest in Q3 2026 (a decline of 96.6%).
- Business Quant data shows RLYB's Non Operating Income at $50.64 million (Q2 2026), $455,000 (Q1 2026) and $560,000 (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Rallybio | 84.05 Mn | -201.02 Mn | - | 778,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 778,000.00 |
| Jun 30, 2026 | 50.64 Mn |
| Mar 31, 2026 | 455,000.00 |
| Dec 31, 2025 | 560,000.00 |
| Sep 30, 2025 | 22.94 Mn |
| Jun 30, 2025 | 641,000.00 |
| Mar 31, 2025 | 818,000.00 |
| Dec 31, 2024 | 994,000.00 |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.29 Mn |
| Mar 31, 2024 | 1.44 Mn |
| Dec 31, 2023 | 1.48 Mn |
| Sep 30, 2023 | 1.64 Mn |
| Jun 30, 2023 | 1.67 Mn |
| Mar 31, 2023 | 1.62 Mn |
| Dec 31, 2022 | 1.10 Mn |
| Sep 30, 2022 | 623,000.00 |
| Jun 30, 2022 | 370,000.00 |
| Mar 31, 2022 | 210,000.00 |
| Dec 31, 2021 | 121,000.00 |
API Access
Rallybio Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=RLYB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "RLYB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=RLYB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();